Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome
Jingyuan Fu(Beijing University of Chinese Medicine), Marc Jan Bonder(University Medical Center Groningen), Biljana Atanasovska(Ss. Cyril and Methodius University in Skopje), Patrick Deelen(University Medical Center Groningen), Serena Sanna(University Medical Center Groningen), Mihai G. Netea(Radboud University Nijmegen), Rudolf A. de Boer(Erasmus MC), Folkert Kuipers(University Medical Center Groningen), Cisca Wijmenga(University Medical Center Utrecht), Alexander Kurilshikov(University Medical Center Groningen), Daria V. Zhernakova(University Medical Center Groningen), Annique Claringbould(University Medical Center Groningen), Urmo Võsa(University Medical Center Groningen), Alexandra Zhernakova(University Medical Center Groningen), Trang Le(University Medical Center Groningen), Lude Franke(University Medical Center Groningen), Marten H. Hofker(Maastricht University)
Cited by 103
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k